Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.

AIDS (London, England)

Volumn 22 Suppl 1, Issue , 2008, Pages

  Beck, Eduard J ^a   Santas, Xenophon M ^a   Delay, Paul R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DRUG COST; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL COOPERATION; METHODOLOGY; ORGANIZATION AND MANAGEMENT;

COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; DRUG COSTS; FINANCIAL MANAGEMENT; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; PROGRAM EVALUATION;

EID: 51549104332     PISSN: None     EISSN: 14735571     Source Type: Journal    
DOI: None     Document Type: Article

References (0)